10.6084/m9.figshare.5121739.v1 Petrova D.T. Petrova D.T. Brehmer F. Brehmer F. Schultze F.C. Schultze F.C. Asif A.R. Asif A.R. Gross O. Gross O. Oellerich M. Oellerich M. Brandhorst G. Brandhorst G. Supplementary Material for: Differential Kidney Proteome Profiling in a Murine Model of Renal Fibrosis under Treatment with Mycophenolate Mofetil Karger Publishers 2011 COL4A3-deficient mice Mycophenolate mofetil Tubulointerstitial fibrosis Epithelial-mesenchymal transition Proteomics 2011-05-26 00:00:00 Dataset https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Differential_Kidney_Proteome_Profiling_in_a_Murine_Model_of_Renal_Fibrosis_under_Treatment_with_Mycophenolate_Mofetil/5121739 <i>Aim:</i> The aim of this study was to investigate the effect of mycophenolate mofetil (MMF) using differential kidney proteome profiling of COL4A3-deficient mice as a model of progressive renal disease. <i>Methods:</i> Histological evaluation of kidney sections was performed. Total protein lysate from kidneys of placebo- and MMF-treated COL4A3-deficient mice was studied for significant differences in protein abundance using 2-dimensional electrophoresis and mass spectrometry. <i>Results:</i> While tubulointerstitial fibrosis in COL4A3-deficient mice was inhibited by MMF, 19 proteins in the kidneys were regulated: 12 with lower (ATPO, TAGL2, CAH1, TPD52, VA0D1, SERPH, GNAL, PSB6, EF1D, OTUB1, NDUS8, and NAPSA) and 7 with higher (ACADM, ACY3, CK054, ACTB/G, ACTB, UBP5, and ACY1) spot intensity. Nine differentially expressed proteins showed interaction potential (ATPO, TPD52, PSB6, EF1D, OTUB1, NAPSA, ACTB, ACTG, and UBP5). <i>Conclusions:</i> The identified proteins take part in different signaling pathways. With the highest probability, the VEGF signaling pathway (TAGL2, EF1D, and ACTB) and hypoxia (CAH1, PSB6, and ACTG) were influenced by MMF in fibrotic conditions. Moreover, MMF may modulate antifibrotic and apoptotic pathways as well as epithelial-mesenchymal transition (EMT). Different signaling pathways may be influenced by MMF therapy. These results suggest an inhibitory effect of MMF on renal EMT in COL4A3-deficient mice. Further studies are necessary to validate these findings.